SELLAS Life Sciences Group, Inc. (SLS)
4.46
-0.18
(-3.88%)
USD |
NASDAQ |
Apr 24, 16:00
4.61
+0.15
(+3.36%)
After-Hours: 20:00
SELLAS Life Sciences Group Total Liabilities (Quarterly) : 7.474M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Spero Therapeutics, Inc. | 9.898M |
| Recursion Pharmaceuticals, Inc. | 397.49M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 50.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 78.34M |
| Shareholders Equity (Quarterly) | 70.87M |
| Debt to Equity Ratio | 0.0141 |
| Current Ratio | 10.72 |
| Net Debt Paydown Yield | -0.01% |